CORONA REMEDIES
Back to Income Statement
|
CORONA REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹240 Cr | ₹1,547 Cr | ₹128 Cr | ₹128 Cr |
What is the latest Operating Profit of CORONA REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹240 Cr |
| Mar2025 | ₹1,547 Cr |
| Mar2024 | ₹128 Cr |
| Mar2023 | ₹128 Cr |
How is Operating Profit of CORONA REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹240 Cr | -84.49 | |
| Mar2025 | ₹1,547 Cr | 1,109.05 | |
| Mar2024 | ₹128 Cr | 0.00 | |
| Mar2023 | ₹128 Cr | - | |
Compare Operating Profit of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,651.6 Cr | 2.3% | 19.5% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 2.3% |
19.5% |
|
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses